{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T10:42:23Z","timestamp":1759488143372,"version":"build-2065373602"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The extent of resection (EOR) is known to impact recurrence free survival in vestibular schwannomas (VS). Identifying predictive factors for complete resection may direct treatment decisions in the future. In recent years there is increasing evidence for the involvement of inflammatory processes in the development and growth of VS. It is currently unclear whether inflammatory changes may also play a role in the extent of resection in VS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this retrospective study, we analyzed clinical data, tumor extension, cystic characteristics and immunohistochemical markers for inflammation (CD68, CD163, CD3, CD8) and proliferation (MIB-1) as potential factors influencing the EOR in 1007 surgically treated primary sporadic VS. With CART-determined specific cut-offs for each inflammation marker, a common inflammatory score from 0 to 2 was determined. Univariate and multivariate analyses were performed for the EOR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Total resection was achieved in 86.5% of cases. Incomplete resection was associated with advanced age (<jats:italic>p<\/jats:italic>\u2009=\u20090.0002), larger tumor size (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) and cystic characteristics on preoperative imaging (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Increased expression of CD163, CD68 and CD3 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, <jats:italic>p<\/jats:italic>\u2009=\u20090.0015 and <jats:italic>p<\/jats:italic>\u2009=\u20090.0024 respectively) was associated with partial tumor resection (PR). CD8 was significant when its CART-determined cut-off was considered (<jats:italic>p<\/jats:italic>\u2009=\u20090.0032). A higher inflammatory score was significantly connected to partial resection (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). In the multivariate analysis, larger size (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), older age (<jats:italic>p<\/jats:italic>\u2009=\u20090.0051), cystic characteristics (<jats:italic>p<\/jats:italic>\u2009=\u20090.0005) and higher CD68 expression (<jats:italic>p<\/jats:italic>\u2009=\u20090.0341) were independently significant factors for partial resection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Advanced age, greater tumor extension, cystic growth and higher infiltration with macrophages are independent factors for a less radical extent of resection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40478-025-02127-4","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T10:17:59Z","timestamp":1759486679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and inflammatory factors associated with the extent of resection in primary, sporadic vestibular schwannomas: A retrospective study"],"prefix":"10.1186","volume":"13","author":[{"given":"Lorenz","family":"D\u00f6rner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa-Maria","family":"Suhm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Ries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor Moura","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Skardelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Tatagiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Schittenhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Behling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"Suppl 5","key":"2127_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT et al (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2012\u20132016. Neuro Oncol 21(Suppl 5):v1\u2013v100","journal-title":"Neuro Oncol"},{"issue":"8","key":"2127_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251","journal-title":"Neuro Oncol"},{"issue":"11","key":"2127_CR3","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/ng.3688","volume":"48","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri S et al (2016) The genomic landscape of Schwannoma. Nat Genet 48(11):1339\u20131348","journal-title":"Nat Genet"},{"issue":"1","key":"2127_CR4","first-page":"1","volume":"40","author":"C Matthies","year":"1997","unstructured":"Matthies C, Samii M (1997) Management of 1000 vestibular schwannomas (Acoustic Neuromas): clinical presentation. Neurosurgery 40(1):1\u201310","journal-title":"Neurosurgery"},{"issue":"1","key":"2127_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/neuonc\/noz153","volume":"22","author":"R Goldbrunner","year":"2020","unstructured":"Goldbrunner R et al (2020) EANO guideline on the diagnosis and treatment of vestibular Schwannoma. Neuro Oncol 22(1):31\u201345","journal-title":"Neuro Oncol"},{"issue":"9","key":"2127_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1055\/a-1130-6321","volume":"99","author":"A Harati","year":"2020","unstructured":"Harati A et al (2020) Management of patients with vestibular Schwannoma type IV. Laryngorhinootologie 99(9):613\u2013619","journal-title":"Laryngorhinootologie"},{"key":"2127_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/sni.sni_129_16","volume":"8","author":"A Harati","year":"2017","unstructured":"Harati A et al (2017) Clinical features, microsurgical treatment, and outcome of vestibular Schwannoma with brainstem compression. Surg Neurol Int 8:45","journal-title":"Surg Neurol Int"},{"key":"2127_CR8","unstructured":"Rosahl S, Lell BC, Hamm M, Iro K (2017) H., Diagnostics and therapy of vestibular schwannomas - an interdisciplinary challenge. GMS Curr Top Otorhinolaryngol - Head Neck Surg, 16"},{"issue":"2","key":"2127_CR9","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1093\/neuros\/nyx515","volume":"82","author":"IM Germano","year":"2018","unstructured":"Germano IM et al (2018) Congress of neurological surgeons systematic review and Evidence-Based guidelines on the role of radiosurgery and radiation therapy in the management of patients with vestibular schwannomas. Neurosurgery 82(2):E49\u2013e51","journal-title":"Neurosurgery"},{"issue":"11","key":"2127_CR10","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1007\/s00701-020-04491-7","volume":"162","author":"D Starnoni","year":"2020","unstructured":"Starnoni D et al (2020) Surgical management for large vestibular schwannomas: a systematic review, meta-analysis, and consensus statement on behalf of the EANS skull base section. Acta Neurochir (Wien) 162(11):2595\u20132617","journal-title":"Acta Neurochir (Wien)"},{"key":"2127_CR11","doi-asserted-by":"publisher","first-page":"1216093","DOI":"10.3389\/fsurg.2023.1216093","volume":"10","author":"M Scheer","year":"2023","unstructured":"Scheer M et al (2023) Recurrences and progression following microsurgery of vestibular Schwannoma. Front Surg 10:1216093","journal-title":"Front Surg"},{"issue":"8","key":"2127_CR12","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/lary.25779","volume":"126","author":"JT Jacob","year":"2016","unstructured":"Jacob JT et al (2016) Volumetric analysis of tumor control following subtotal and near-total resection of vestibular Schwannoma. Laryngoscope 126(8):1877\u20131882","journal-title":"Laryngoscope"},{"issue":"8","key":"2127_CR13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1097\/MAO.0000000000003593","volume":"43","author":"RJ Macielak","year":"2022","unstructured":"Macielak RJ et al (2022) Predicting extent of microsurgical resection of sporadic vestibular Schwannoma. Otol Neurotol 43(8):950\u2013955","journal-title":"Otol Neurotol"},{"issue":"2","key":"2127_CR14","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1097\/MAO.0000000000004073","volume":"45","author":"L Zhang","year":"2024","unstructured":"Zhang L et al (2024) Identifying tumor microenvironment biomarkers in adherent and cystic vestibular schwannomas. Otol Neurotol 45(2):e113\u2013e122","journal-title":"Otol Neurotol"},{"issue":"1","key":"2127_CR15","doi-asserted-by":"publisher","first-page":"14561","DOI":"10.1038\/s41598-024-64597-1","volume":"14","author":"BH Duhon","year":"2024","unstructured":"Duhon BH et al (2024) Tumor Biomechanical stiffness by magnetic resonance elastography predicts surgical outcomes and identifies biomarkers in vestibular Schwannoma and meningioma. Sci Rep 14(1):14561","journal-title":"Sci Rep"},{"issue":"11","key":"2127_CR16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/jmg.40.11.802","volume":"40","author":"C Warren","year":"2003","unstructured":"Warren C et al (2003) Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J Med Genet 40(11):802\u2013806","journal-title":"J Med Genet"},{"issue":"6","key":"2127_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00428-012-1236-9","volume":"460","author":"M de Vries","year":"2012","unstructured":"de Vries M et al (2012) Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas. Virchows Arch 460(6):629\u2013636","journal-title":"Virchows Arch"},{"issue":"1","key":"2127_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0040-1716688","volume":"83","author":"CJ Hannan","year":"2022","unstructured":"Hannan CJ et al (2022) Beyond antoni: A surgeon\u2019s guide to the vestibular Schwannoma microenvironment. J Neurol Surg B Skull Base 83(1):1\u201310","journal-title":"J Neurol Surg B Skull Base"},{"issue":"1","key":"2127_CR19","first-page":"vdaa023","volume":"2","author":"CJ Hannan","year":"2020","unstructured":"Hannan CJ et al (2020) The inflammatory microenvironment in vestibular Schwannoma. Neurooncol Adv 2(1):vdaa023","journal-title":"Neurooncol Adv"},{"issue":"7203","key":"2127_CR20","first-page":"436","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A et al (2008) Cancer-related Inflamm Nat 454(7203):436\u2013444","journal-title":"Cancer-related Inflamm Nat"},{"key":"2127_CR21","doi-asserted-by":"crossref","unstructured":"Leisz S et al (2022) Vestibular Schwannoma volume and tumor growth correlates with macrophage marker expression. Cancers (Basel), 14(18)","DOI":"10.3390\/cancers14184429"},{"issue":"2","key":"2127_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/MAO.0b013e31827c9fbf","volume":"34","author":"M de Vries","year":"2013","unstructured":"de Vries M et al (2013) Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas. Otol Neurotol 34(2):347\u2013352","journal-title":"Otol Neurotol"},{"issue":"3","key":"2127_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/MAO.0000000000002542","volume":"41","author":"VC Pandrangi","year":"2020","unstructured":"Pandrangi VC et al (2020) An update on epidemiology and management trends of vestibular schwannomas. Otol Neurotol 41(3):411\u2013417","journal-title":"Otol Neurotol"},{"issue":"3","key":"2127_CR24","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.3171\/2012.7.FOCUS12199","volume":"33","author":"RK Gurgel","year":"2012","unstructured":"Gurgel RK et al (2012) Facial nerve outcomes after surgery for large vestibular schwannomas: do surgical approach and extent of resection matter? Neurosurg Focus 33(3):E16","journal-title":"Neurosurg Focus"},{"key":"2127_CR25","doi-asserted-by":"crossref","unstructured":"Seol HJ et al (2006) Optimal extent of resection in vestibular Schwannoma surgery: relationship to recurrence and facial nerve preservation. Neurol Med Chir (Tokyo), 46(4): p. 176\u2009\u2013\u200980; discussion 180-1.","DOI":"10.2176\/nmc.46.176"},{"issue":"5","key":"2127_CR26","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3171\/2010.11.JNS10257","volume":"114","author":"ME Sughrue","year":"2011","unstructured":"Sughrue ME et al (2011) Extent of resection and the long-term durability of vestibular Schwannoma surgery. J Neurosurg 114(5):1218\u20131223","journal-title":"J Neurosurg"},{"issue":"1","key":"2127_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/019459989110400117","volume":"104","author":"JL Kemink","year":"1991","unstructured":"Kemink JL et al (1991) Operative management of acoustic neuromas: the priority of neurologic function over complete resection. Otolaryngol Head Neck Surg 104(1):96\u201399","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"2127_CR28","first-page":"11","volume":"40","author":"M Samii","year":"1997","unstructured":"Samii M, Matthies C (1997) Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them. Neurosurgery 40(1):11\u201321 discussion 21\u2009\u2013\u20093","journal-title":"Neurosurgery"},{"issue":"4","key":"2127_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1054\/jocn.2001.1003","volume":"9","author":"DP Muzumdar","year":"2002","unstructured":"Muzumdar DP, Goel A, Pakhmode CK (2002) Multicystic acoustic neurinoma: report of two cases. J Clin Neurosci 9(4):453\u2013455","journal-title":"J Clin Neurosci"},{"key":"2127_CR30","doi-asserted-by":"publisher","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y et al (2020) Tumor-Associated macrophages in tumor immunity. Front Immunol 11:583084","journal-title":"Front Immunol"},{"key":"2127_CR31","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves VM et al (2021) Macrophage and lymphocyte infiltration is associated with volumetric tumor size but not with volumetric growth in the T\u00fcbingen Schwannoma cohort. Cancers (Basel), 13(3)","DOI":"10.3390\/cancers13030466"},{"key":"2127_CR32","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves VM et al (2021) Correction: Gon\u00e7alves. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the T\u00fcbingen Schwannoma Cohort. Cancers 13, 466. Cancers (Basel), 2023. 15(2)","DOI":"10.3390\/cancers15020377"},{"issue":"6","key":"2127_CR33","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3171\/2019.7.JNS19879","volume":"133","author":"A Perry","year":"2019","unstructured":"Perry A et al (2019) Predominance of M1 subtype among tumor-associated macrophages in phenotypically aggressive sporadic vestibular Schwannoma. J Neurosurg 133(6):1637\u20131645","journal-title":"J Neurosurg"},{"issue":"8","key":"2127_CR34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA (2004) Fibrotic disease and the TH1\/TH2 paradigm. Nat Rev Immunol 4(8):583\u2013594","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2127_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000522417","volume":"8","author":"S Wang","year":"2022","unstructured":"Wang S, Liang Y, Dai C (2022) Metabolic regulation of fibroblast activation and proliferation during organ fibrosis. Kidney Dis (Basel) 8(2):115\u2013125","journal-title":"Kidney Dis (Basel)"},{"key":"2127_CR36","doi-asserted-by":"crossref","unstructured":"Sung JY, Lee JW (2024) Cancer-Associated Fibroblast Subtypes Reveal Distinct Gene Signatures in the Tumor Immune Microenvironment of Vestibular Schwannoma. Cells, 13(19)","DOI":"10.3390\/cells13191669"},{"key":"2127_CR37","doi-asserted-by":"publisher","first-page":"650105","DOI":"10.3389\/fimmu.2021.650105","volume":"12","author":"S Tu","year":"2021","unstructured":"Tu S et al (2021) Crosstalk between Tumor-Associated Microglia\/Macrophages and CD8-Positive T cells plays a key role in glioblastoma. Front Immunol 12:650105","journal-title":"Front Immunol"},{"issue":"7","key":"2127_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8(7):523\u2013532","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2127_CR39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A et al (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549\u2013555","journal-title":"Trends Immunol"},{"key":"2127_CR40","doi-asserted-by":"crossref","unstructured":"Mahboubi H et al (2023) Comparison of Surgeons\u2019 Assessment of the Extent of Vestibular Schwannoma Resection with Immediate Post Operative and Follow-Up Volumetric MRI Analysis. Brain Sci, 13(10)","DOI":"10.3390\/brainsci13101490"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02127-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02127-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02127-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T10:18:04Z","timestamp":1759486684000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02127-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2127"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02127-4","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institution\u2019s Ethics Committee and conducted in accordance with the declaration of Helsinki. (Projekt number: 452\/2021BO2). Tumor tissue and clinical data were used only with patient consent, as defined by the institution\u2019s Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}